Battery Ventures to Take Private Enzo Biochem in All-Cash Transaction
August 28, 2025
Battery Ventures will acquire Enzo Biochem in an all-cash transaction for approximately $37 million, valuing Enzo at $0.70 per share. The deal was announced after Enzo’s board entered into an Agreement and Plan of Merger on June 23, 2025, and is expected to close in the third quarter of 2025 subject to customary closing conditions and shareholder approval.
- Buyers
- Battery Ventures, Bethpage Parent, Inc.
- Targets
- Enzo Biochem, Inc.
- Industry
- Healthcare Services
- Location
- New York, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.